Advancing FDA’s Mission by Targeting Key Areas for Regulatory Science Investment and Innovation
By RADM Denise Hinton & Tina Morrison PhD – We live in an era of rapidly changing technological advancements that enable science to evolve at an unprecedented pace. At the U.S. Food and Drug Administration, we rely on our scientific and technical experts to make sound, science- and evidence-based regulatory decisions to protect and promote public health.